Exercise and Colon Cancer

Completed · Not applicable

Conditions studied: Stage II Colon Cancer, Stage III Colon Cancer

In brief

Despite the success of surgery and chemotherapy among people with colon cancer, 30-50% of patients develop recurrent disease. Physical activity has emerged as a potential lifestyle intervention to reduce cancer recurrence and improve survival among people with colon cancer (CC). This pilot study aims to identify the dose-response effects of aerobic exercise on molecular and cellular pathways associated with physical activity and CC outcomes among patients with stage II and III CC.

Key facts

Study ID

NCT02250053

Run by

Abramson Cancer Center at Penn Medicine

People needed

44

Starts

2015-12-01

Expected to finish

2016-01-15

Last updated by the study team

2020-04-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• histologically confirmed TNM stage II-III CC;
• completed surgical resection and adjuvant chemotherapy (if applicable) within 1-24 months before entering the study;
• ≤120 min/wk of self-reported moderate or vigorous intensity physical activity using the Paffenbarger physical activity questionnaire;
• age ≥18 years;
• written physician approval;
• no additional surgery planned within the 6-month intervention (including colostomy reversal);
• ability to walk unaided for 6-minutes;
• no contraindications to exercise using the PA readiness questionnaire (PAR-Q), unless physician approves participation with specific knowledge of this contraindication.

You may not qualify if…

• history of another primary invasive cancer (other than non-melanoma skin-cancer);
• evidence of metastatic CC (i.e., TNM M1);
• planning to receive any additional adjuvant chemotherapy;
• pregnant or breast feeding;
• unable to provide baseline blood sample;
• cardiac conditions, including the following:
• myocardial infarction or coronary revascularization procedure within prior 3 months;
• uncontrolled hypertension (systolic ≥180 mmHg or diastolic ≥100 mmHg);
• high-risk or uncontrolled arrhythmias;
• clinically significant valvular disease;
• decompensated heart failure;
• known aortic aneurysm;
• any other condition that may impede testing of the study hypothesis or make it unsafe to engage in the exercise program (determined by the investigative team).

Where it is running

• Abramson Cancer Center of the University of Pennsylvania — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.